Scenarios that move SUPN
Supernus Pharmaceuticals, Inc. - Common Stock
Scenarios that move SUPN: 4 analyses, 2 positive, 2 negative.
- · Viatris to acquire Pacira for $1.65B in pain portfolio deal — ▲ · impact +14 · confidence low · horizon weeks
- · Pacira BioSciences shares skyrocket in today's trading — ▲ · impact +30 · confidence medium · horizon weeks
- · Xenon files epilepsy NDA as depression study setback weighs — ▼ · impact -18 · confidence high · horizon quarters
- · Definium reports second Phase III success in anxiety program — ▼ · impact -18 · confidence low · horizon quarters